We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Rules Santarus Patents on Zegerid Are Invalid
Court Rules Santarus Patents on Zegerid Are Invalid
April 27, 2010
A federal court has ruled that five patents on Santarus’ heartburn drug Zegerid are invalid due to obviousness, a move that could pave the way for generic versions of the drug to enter the market.